VisusNano Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

VisusNano General Information

Description

Developer of a drug-eluting intraocular lens technology designed to facilitate cataract surgery. The company's lens can reduce or remove risks associated with cataract surgery, such as intraocular inflammation, infection, and opacification, enabling physicians to improve patient outcomes, obviating the need for eye drops, and avoiding the need for laser treatment after surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lab 5 Building 500
  • Discovery park, Kent
  • Sandwich CT13 9ND
  • England, United Kingdom
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
  • Lab 5 Building 500
  • Discovery park, Kent
  • Sandwich CT13 9ND
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VisusNano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Mar-2026 Completed Pre-Clinical Trials
8. Later Stage VC 31-May-2024 Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 17-May-2022 Completed Pre-Clinical Trials
6. Grant 02-Jun-2020 Completed Pre-Clinical Trials
5. Accelerator/Incubator 15-May-2019 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 04-Apr-2019 Completed Startup
3. Accelerator/Incubator 13-Jul-2018 Completed Startup
2. Accelerator/Incubator 22-Dec-2017 $42.5K Completed Startup
1. Accelerator/Incubator 16-Mar-2016 $42.5K $42.5K Completed Startup
To view VisusNano’s complete valuation and funding history, request access »

VisusNano Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view VisusNano’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VisusNano Patents

VisusNano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202503488-D0 Drug eluting devices and attachments for intraocular lenses Inactive 10-Mar-2025
GB-202314432-D0 Drug eluting devices for intraocular lenses Inactive 20-Sep-2023
WO-2025062017-A1 Drug eluting devices for intraocular lenses Inactive 20-Sep-2023
EP-3777769-A1 Drug eluting coating for medical devices Active 29-Feb-2016
EP-3777769-B1 Drug eluting coating for medical devices Active 29-Feb-2016 A61L27/54
To view VisusNano’s complete patent history, request access »

VisusNano Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VisusNano Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arrowfield Capital Angel Group Minority
Discovery Park Ventures Family Office Minority
Innvotec Venture Capital Minority
Innovate UK Government Minority
MassChallenge Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

VisusNano FAQs

  • When was VisusNano founded?

    VisusNano was founded in 2016.

  • Where is VisusNano headquartered?

    VisusNano is headquartered in Sandwich, United Kingdom.

  • What is the size of VisusNano?

    VisusNano has 7 total employees.

  • What industry is VisusNano in?

    VisusNano’s primary industry is Drug Delivery.

  • Is VisusNano a private or public company?

    VisusNano is a Private company.

  • What is VisusNano’s current revenue?

    The current revenue for VisusNano is .

  • How much funding has VisusNano raised over time?

    VisusNano has raised $2.49M.

  • Who are VisusNano’s investors?

    Arrowfield Capital, Discovery Park Ventures, Innvotec, Innovate UK, and MassChallenge are 5 of 8 investors who have invested in VisusNano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process